Literature DB >> 15878743

Oxidative stress in patients with phenylketonuria.

L R Sirtori1, C S Dutra-Filho, D Fitarelli, A Sitta, A Haeser, A G Barschak, M Wajner, D M Coelho, S Llesuy, A Belló-Klein, R Giugliani, M Deon, C R Vargas.   

Abstract

Phenylketonuria (PKU) is an autossomal recessive disease caused by phenylalanine-4-hydroxylase deficiency, which is a liver-specific enzyme that catalyzes the hydroxylation of l-phenylalanine (Phe) to l-tyrosine (Tyr). The deficiency of this enzyme leads to the accumulation of Phe in the tissues and plasma of patients. The clinical characterization of this disease is mental retardation and other neurological features. The mechanisms of brain damage are poorly understood. Oxidative stress is observed in some inborn errors of intermediary metabolism owing to the accumulation of toxic metabolites leading to excessive free radical production and may be a result of restricted diets on the antioxidant status. In the present study we evaluated various oxidative stress parameters, namely thiobarbituric acid-reactive species (TBA-RS) and total antioxidant reactivity (TAR) in the plasma of PKU patients. The activities of the antioxidant enzymes catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were also measured in erythrocytes from these patients. It was observed that phenylketonuric patients present a significant increase of plasma TBA-RS measurement, indicating a stimulation of lipoperoxidation, as well as a decrease of plasma TAR, reflecting a deficient capacity to rapidly handle an increase of reactive species. The results also showed a decrease of erythrocyte GSH-Px activity. Therefore, it is presumed that oxidative stress is involved in the pathophysiology of the tissue damage found in PKU.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15878743     DOI: 10.1016/j.bbadis.2005.02.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  38 in total

Review 1.  Oxidative stress in phenylketonuria: what is the evidence?

Authors:  Graziela S Ribas; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

2.  PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pah(enu2) mice.

Authors:  Jennifer E Embury; Catherine E Charron; Anatoly Martynyuk; Andreas G Zori; Bin Liu; Syed F Ali; Neil E Rowland; Philip J Laipis
Journal:  Brain Res       Date:  2006-11-15       Impact factor: 3.252

3.  Outcomes of phenylketonuria with relevance to follow-up.

Authors:  F J van Spronsen; A Bélanger-Quintana
Journal:  JIMD Rep       Date:  2011-06-22

4.  Phenylpyruvic acid decreases glucose-6-phosphate dehydrogenase activity in rat brain.

Authors:  Andrea Pereira Rosa; Carlos Eduardo Dias Jacques; Tarsila Barros Moraes; Clóvis M D Wannmacher; Angela de Mattos Dutra; Carlos Severo Dutra-Filho
Journal:  Cell Mol Neurobiol       Date:  2012-04-04       Impact factor: 5.046

5.  Regular exercise prevents oxidative stress in the brain of hyperphenylalaninemic rats.

Authors:  Priscila Nicolao Mazzola; Melaine Terra; Andrea Pereira Rosa; Caroline Paula Mescka; Tarsila Barros Moraes; Bruna Piccoli; Carlos Eduardo Jacques; Giovana Dalazen; Marcelo Xavier Cortes; Juliana Coelho; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2011-09-27       Impact factor: 3.584

Review 6.  Oxidative stress in phenylketonuria: future directions.

Authors:  Júlio César Rocha; Maria João Martins
Journal:  J Inherit Metab Dis       Date:  2011-11-25       Impact factor: 4.982

7.  Investigation of oxidative stress parameters in treated phenylketonuric patients.

Authors:  A Sitta; A G Barschak; M Deon; T Terroso; R Pires; R Giugliani; C S Dutra-Filho; M Wajner; C R Vargas
Journal:  Metab Brain Dis       Date:  2006-12-05       Impact factor: 3.584

8.  L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.

Authors:  Angela Sitta; Alethéa G Barschak; Marion Deon; Jurema F de Mari; Amanda T Barden; Camila S Vanzin; Giovana B Biancini; Ida V D Schwartz; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2008-09-24       Impact factor: 5.046

9.  Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats.

Authors:  Carolina G Fernandes; Guilhian Leipnitz; Bianca Seminotti; Alexandre U Amaral; Angela Zanatta; Carmen R Vargas; Carlos S Dutra Filho; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2009-09-23       Impact factor: 5.046

10.  Oxidative stress in plasma from maple syrup urine disease patients during treatment.

Authors:  Alethéa G Barschak; Angela Sitta; Marion Deon; Amanda T Barden; Carlos S Dutra-Filho; Moacir Wajner; Carmen R Vargas
Journal:  Metab Brain Dis       Date:  2007-11-17       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.